Table 3. Plasma amino acid level profile.
| pre-CR | post-CR | normal range | |
|---|---|---|---|
| Gly (nmol/ml) | 255.8 ± 89.7 | 251.6 ± 74.3 | 151.0–351.0 |
| Ala (nmol/ml) | 409.4 ± 111.6 | 404.6 ± 111.7 | 208.7–522.7 |
| Ser (nmol/ml) | 107.1 ± 24.2 | 105.1 ± 28.5 | 72.4–164.5 |
| Thr (nmol/ml) | 101.7 ± 19.4 | 103.0 ± 23.2 | 66.5–188.9 |
| Val (nmol/ml) | 240.3 ± 37.1 | 251.6 ± 47.3 | 147.8–307.0 |
| Ile (nmol/ml) | 71.7 ± 15.3 | 77.1 ± 20.9 | 43.0–112.8 |
| Leu (nmol/ml) | 125.8 ± 22.7 | 131.8 ± 29.1 | 76.6–171.3 |
| Lys (nmol/ml) | 197.1 ± 38.6 | 200.7 ± 37.9 | 108.7–242.2 |
| Arg (nmol/ml) | 99.6 ± 20.6 | 98.1 ± 23.5 | 53.6–133.6 |
| His (nmol/ml) | 72.9 ± 10.6 | 76.7 ± 10.8 | 59.0–92.0 |
| Tyr (nmol/ml) | 71.9 ± 12.9 | 70.6 ± 17.2 | 40.4–90.3 |
| Phe (nmol/ml) | 67.0 ± 10.3 | 67.8 ± 13.8 | 42.6–75.7 |
| Trp (nmol/ml) | 54.2 ± 9.8 | 58.4 ± 9.5 | 37.0–74.9 |
| Met (nmol/ml) | 24.6 ± 5.9 | 27.0 ± 5.8 | 18.9–40.5 |
| Cys (nmol/ml) | 66.4 ± 18.6 | 70.4 ± 22.8 | 13.7–28.3 |
| Pro (nmol/ml) | 186.6 ± 53.5 | 183.7 ± 70.0 | 77.8–272.7 |
| Gln (nmol/ml) | 622.1 ± 65.1 | 604.4 ± 74.8 | 422.1–703.8 |
| Glu (nmol/ml) | 50.7 ± 31.3 | 48.7 ± 22.5 | 12.6–62.5 |
| Asn (nmol/ml) | 45.6 ± 17.3 | 47.4 ± 15.7 | 44.7–96.8 |
| Cit (nmol/ml) | 45.2 ± 17.3 | 47.4 ± 15.7 | 17.1–42.6 |
| Orn (nmol/ml) | 24.6 ± 5.9 | 27.0 ± 5.8 | 31.3–104.7 |
| Tau (nmol/ml) | 54.8 ± 15.4 | 55.0 ± 14.6 | 39.5–93.2 |
pre-CR: before phase II cardiac rehabilitation program; post-CR: after phase II cardiac rehabilitation program; Gly: glycine; Ala: alanine; Ser: serine; Thr: threonine; Val: valine; Ile: isoleucine; Leu: leucine; Lys: lysine; Arg: arginine; His: histidine; Tyr: tyrosine; Phe: phenylalanine; Trp: tryptophan; Met: methionine; Cys: cysteine; Pro: proline; Gln: glutamine; Glu: glutamic acid; Asn: asparagine; Cit: citrulline; Orn: ornithine; Tau: taurine. Between pre-CR and post-CR by Wilcoxon signed-rank test. Values are means ± SD, n=12